FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Dr. Reddy's Laboratories Succinylcholine Chloride Injection Recall

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-D…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Oct 15, 2025
Recall ID
D-0008-2026
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Succinylcholine Chloride Injection starting Sep 26, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0008-2026 on Oct 15, 2025. Reason: Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration. Status: Ongoing.

Why it was recalled

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Product description

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Lot numbers, UPCs & expiration codes

Lot # K250048

Where it was sold

Nationwide within the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0008-2026
Classification
Class II
Status
Ongoing
Recall initiated
Sep 26, 2025
FDA report date
Oct 15, 2025
Quantity
571 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0008-2026, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
97690
Address
600 College Rd E Ste 4000
Code information
Lot # K250048
Postal code
08540-6636
Report date
Oct 15, 2025
Product type
Drugs
Recall number
D-0008-2026
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
571 vials
Reason for recall
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Distribution pattern
Nationwide within the USA.
Recall initiation date
Sep 26, 2025
Initial firm notification
Letter
Center classification date
Oct 7, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0008-2026, published Oct 15, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls